Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2010 | 1 |
2011 | 1 |
2012 | 1 |
2018 | 1 |
2023 | 3 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial.
Lancet. 2023 May 13;401(10388):1584-1594. doi: 10.1016/S0140-6736(23)00569-X. Epub 2023 Apr 1.
Lancet. 2023.
PMID: 37015244
Clinical Trial.
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.
Rheault MN, Alpers CE, Barratt J, Bieler S, Canetta P, Chae DW, Coppock G, Diva U, Gesualdo L, Heerspink HJL, Inrig JK, Kirsztajn GM, Kohan D, Komers R, Kooienga LA, Lieberman K, Mercer A, Noronha IL, Perkovic V, Radhakrishnan J, Rote W, Rovin B, Tesar V, Trimarchi H, Tumlin J, Wong MG, Trachtman H; DUPRO Steering Committee and DUPLEX Investigators.
Rheault MN, et al.
N Engl J Med. 2023 Dec 28;389(26):2436-2445. doi: 10.1056/NEJMoa2308550. Epub 2023 Nov 3.
N Engl J Med. 2023.
PMID: 37921461
Clinical Trial.
Item in Clipboard
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators.
Rovin BH, et al.
Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3.
Lancet. 2023.
PMID: 37931634
Clinical Trial.
Item in Clipboard
Role of Pattern Recognition Receptors in KSHV Infection.
Uppal T, Sarkar R, Dhelaria R, Verma SC.
Uppal T, et al. Among authors: dhelaria r.
Cancers (Basel). 2018 Mar 20;10(3):85. doi: 10.3390/cancers10030085.
Cancers (Basel). 2018.
PMID: 29558453
Free PMC article.
Review.
Item in Clipboard
Is varenicline effectiveness declining in randomized trials?
Dhelaria RK, Rothberg M.
Dhelaria RK, et al.
Arch Intern Med. 2011 Oct 24;171(19):1770-1; author reply 1771-2. doi: 10.1001/archinternmed.2011.493.
Arch Intern Med. 2011.
PMID: 22025439
No abstract available.
Item in Clipboard
Effectiveness of varenicline for smoking cessation at 2 urban academic health centers.
Dhelaria RK, Friderici J, Wu K, Gupta E, Khan C, Rothberg MB.
Dhelaria RK, et al.
Eur J Intern Med. 2012 Jul;23(5):461-4. doi: 10.1016/j.ejim.2012.03.017. Epub 2012 May 3.
Eur J Intern Med. 2012.
PMID: 22726377
Item in Clipboard
Microtumor embolization leading to cor pulmonale: an extremely rare complication of ovarian cancer.
Dhelaria RK, Acevedo C, Fadaili A, Crisi G.
Dhelaria RK, et al.
South Med J. 2010 Jul;103(7):720. doi: 10.1097/SMJ.0b013e3181e1e419.
South Med J. 2010.
PMID: 20531033
No abstract available.
Item in Clipboard
Cite
Cite